Single Use Device Endoscopy for the Diagnosis of Acute Bacterial Rhinosinusitis in Primary Care (Sinus-Endo)
Primary Purpose
Acute Bacterial Sinusitis
Status
Unknown status
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
JGG endoscope(R)
Sponsored by
About this trial
This is an interventional diagnostic trial for Acute Bacterial Sinusitis focused on measuring Rhinosinusitis, upper respiratory tract infection, antibiotic, endoscopy, Otolaryngology, primary care
Eligibility Criteria
Inclusion Criteria:
- Adults patients aged ≥18 years, with acute rhinosinusitis
- Duration: worsening of symptoms after 5 days after onset of symptoms or if symptoms persist for more than 10 days, but no longer than 28 days. In addition, Criteria 1 and 2 must be fulfilled.
Criteria 1 for acute rhinosinusitis:
[Nasal blockage/obstruction/congestion OR Nasal Discharge (anterior/ posterior nasal drip)] AND [Facial pain/ pressure OR Reduction or loss of smell]
Criteria 2 for acute bacterial rhinosinusitis
Indicated by the presence of at least one of the following symptoms:
- discoloured discharge (unilateral predominance)
- severe local pain (unilateral predominance)
- fever, that is >38°C
- elevated inflammatory markers (CRP)
- 'double sickening' whereby the patient's condition deteriorates.
Exclusion Criteria:
- Not being able to provide written informed consent in German (due to any mental or intellectual problem or other reasons)
- Not being available for follow-up
- Previous participation in Sinus-Endo study
- Use of antibiotic the last 4 weeks
- Known pathology or malformation of the sinuses or nasal cavity (like polyposis)
- Known pregnancy
- Allergic reactions to local anaesthetics
- Anticoagulation therapy
Sites / Locations
- Praxis VogtRecruiting
- Hausarztpraxis Muttenz AGRecruiting
- mediX toujours PrattelnRecruiting
- HNO Klinik, University Hospital BaselRecruiting
- mediX toujours BaselRecruiting
- Praxis Hammer
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Diagnostic with JGG endoscope
Arm Description
Outcomes
Primary Outcome Measures
Prevalence of successful JGG endoscope® application
The number of patients with successful visualization and sample collection from the middle meatus with the JGG endoscope®
Prevalence of complications
The number of patients with complications related to the examination with the JGG endoscope®.
Secondary Outcome Measures
Influence of JGG endoscope® to support the decision of antibiotic prescribing
After each examination with the JGG endoscope, each physician will report on a Likert scale with five categories how the physician would judge usefulness of the device for decision to prescribe antibiotics.(The examination with the JGG endoscope(R) supported my decision whether to prescribe antibiotics or not; possible answers 1: don't agree, 2: partially don't agree, 3: neutral, 4: partially agree, 5: agree). The findings will be presented descriptively.
Prevalence of bacterial Rhinosinusitis
The number of patient with culture proven acute bacterial rhinosinusitis from samples of the middle meatus diagnosed by the JGG endoscope®
Prevalence of any or deferred antibiotic prescriptions
The number of patients with any or deferred antibiotic prescriptions in patients with acute rhinosinusitis diagnosed by the JGG endoscope®
Number of days with restrictions
The mean days with restrictions and symptoms from acute rhinosinusitis at Day 14 in patients with positive and negative cultures as diagnosed with the JGG endoscope®
Patients's acceptability of JGG endoscope®
The patients' acceptability of the device will be assessed on Likert scale (If I would suffer again from an akute sinusitis, I would again agree being investigated with the JGG endoscope(R); possible answers 1: don't agree, 2: partially don't agree, 3: don't know, 4: partially agree, 5: agree). The findings will be presented descriptively.
Physicians' acceptability by a global usefulness rating on Likert scales
The physicians' acceptability will be evaluated by a global usefulness rating on Likert scales with five categories after recruitment completion (The ratio of additional effort due to the JGG endoscope(R) and the newly gained information is good, possible answers 1: don't agree, 2: partially don't agree, 3: neutral, 4: partially agree, 5: agree). The findings will be presented descriptively.
Prevalence of serious adverse events
The number of patients with any serious adverse event within the two weeks follow-up
Full Information
NCT ID
NCT03766568
First Posted
December 3, 2018
Last Updated
January 13, 2020
Sponsor
Dominik Glinz
Collaborators
University Hospital, Basel, Switzerland
1. Study Identification
Unique Protocol Identification Number
NCT03766568
Brief Title
Single Use Device Endoscopy for the Diagnosis of Acute Bacterial Rhinosinusitis in Primary Care
Acronym
Sinus-Endo
Official Title
Single Use Device Endoscopy for the Diagnosis of Acute Bacterial Rhinosinusitis in Primary Care: A Pilot and Feasibility Study
Study Type
Interventional
2. Study Status
Record Verification Date
January 2020
Overall Recruitment Status
Unknown status
Study Start Date
December 17, 2018 (Actual)
Primary Completion Date
May 31, 2020 (Anticipated)
Study Completion Date
September 30, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Dominik Glinz
Collaborators
University Hospital, Basel, Switzerland
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a pilot study to assess the first time use of the JGG endoscope® in humans and in primary care. The JGG endoscope® is attached to a Heine® otoscope and allows to inspect and to collect samples from the middle meatus of the sinus. The JGG endoscope® is sterile packaged, for one way use and disposable.
Detailed Description
Acute rhinosinusitis is one of the most common reasons for consultations and antibiotic prescriptions in primary care although the condition is primarily of viral origin. The main reason for antibiotic overuse in acute rhinosinusitis is the lack of diagnostic tests of sufficient accuracy to confirm or rule out the diagnosis of acute bacterial rhinosinusitis (ABRS).
The gold standard for the diagnosis of ABRS is a bacterial culture from sinus maxillary puncture. This procedure is painful, prone to complications and only done in selected patients by oto-rhino-laryngology (ORL) specialists or for research purposes. Therefore, endoscopy of the middle meatus and collection of diagnostic material from the ostium draining the sinus is the diagnostic method of choice for ABRS and routinely used by ORL specialists in house and elsewhere. In patients with clinical symptoms of sufficient severity and duration (typically 5-10 days) for ABRS, endoscopy has a sensitivity of 85.7% (95% confidence interval, 56.2-97.5), specificity of 90.6% (73.8-97.5), positive predictive value of 80% (51.4-94.7), negative predictive value of 93.5% (77.2-98.9) for culture proven ABRS when compared with cultures gained from sinus puncture. Because of high upfront costs and logistical reason (disinfection) endoscopy is not used in general practice or internal medicine.
Dr. Jens G. Hansen has developed the disposable JGG endoscope® (JGG stands for the surnames of the inventor and his wife) which can be attached to the new generation of Heine® otoscopes with a LED light source that allows the inspection of the ostium in the middle meatus and collection of material for bacterial culture for the diagnosis of ABRS in primary care. After local anaesthesiology of the cavum nasi a sample material for cultures can be gained (earliest 10 min after local anaesthesia). The diagnostic procedure poses patients at minimal risk for complications and is of very little and short-termed discomfort.
In a pilot study the investigators would like to test the JGG endoscope® in 60 patients with suspected acute bacterial rhinosinusitis in the ORL unit of the University Hospital Basel and selected general practices that collaborate with the Centre for Primary Health Care of the University of Basel.
Objectives:
To assess the feasibility of visualization and sample collection from the middle meatus with the JGG endoscope® in patients with clinically diagnosed acute bacterial rhinosinusitis in Swiss primary care setting
to investigate whether the JGG endoscope® supports the decision of antibiotic prescribing
to assess patients' and physicians' acceptability of the examination with the JGG endoscope®
to investigate the prevalence of culture proven acute bacterial rhinosinusitis from samples of the middle meatus by the JGG endoscope® in patients with clinically diagnosed acute rhinosinusitis
to investigate the number of patients with acute rhinosinusitis diagnosed by the JGG endoscope® with any and/or deferred antibiotic prescriptions
to investigate the days with restrictions and symptoms in patients with acute rhinosinusitis with positive and negative bacterial cultures diagnosed by the JGG endoscope®
to investigate any serious adverse event related to the JGG endoscope®.
Design Prospective observational cohort study (single arm study)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Bacterial Sinusitis
Keywords
Rhinosinusitis, upper respiratory tract infection, antibiotic, endoscopy, Otolaryngology, primary care
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Prospective observational cohort study (single arm study)
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Diagnostic with JGG endoscope
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
JGG endoscope(R)
Intervention Description
The JGG endoscope(R) is attached to the new generation of Heine® otoscopes with a LED light source that allows the inspection of the ostium in the middle meatus and collection of material for bacterial culture for the diagnosis of ABRS in primary care. After local anaesthesiology of the cavum nasi a sample material for cultures can be gained (earliest 10 min after local anaesthesia). The diagnostic procedure poses patients at minimal risk for complications and is of very little and short-termed discomfort.
Primary Outcome Measure Information:
Title
Prevalence of successful JGG endoscope® application
Description
The number of patients with successful visualization and sample collection from the middle meatus with the JGG endoscope®
Time Frame
Baseline Day 0
Title
Prevalence of complications
Description
The number of patients with complications related to the examination with the JGG endoscope®.
Time Frame
2 weeks follow-up
Secondary Outcome Measure Information:
Title
Influence of JGG endoscope® to support the decision of antibiotic prescribing
Description
After each examination with the JGG endoscope, each physician will report on a Likert scale with five categories how the physician would judge usefulness of the device for decision to prescribe antibiotics.(The examination with the JGG endoscope(R) supported my decision whether to prescribe antibiotics or not; possible answers 1: don't agree, 2: partially don't agree, 3: neutral, 4: partially agree, 5: agree). The findings will be presented descriptively.
Time Frame
one weeks follow-up
Title
Prevalence of bacterial Rhinosinusitis
Description
The number of patient with culture proven acute bacterial rhinosinusitis from samples of the middle meatus diagnosed by the JGG endoscope®
Time Frame
2 weeks follow-up
Title
Prevalence of any or deferred antibiotic prescriptions
Description
The number of patients with any or deferred antibiotic prescriptions in patients with acute rhinosinusitis diagnosed by the JGG endoscope®
Time Frame
2 weeks follow-up
Title
Number of days with restrictions
Description
The mean days with restrictions and symptoms from acute rhinosinusitis at Day 14 in patients with positive and negative cultures as diagnosed with the JGG endoscope®
Time Frame
2 weeks follow-up
Title
Patients's acceptability of JGG endoscope®
Description
The patients' acceptability of the device will be assessed on Likert scale (If I would suffer again from an akute sinusitis, I would again agree being investigated with the JGG endoscope(R); possible answers 1: don't agree, 2: partially don't agree, 3: don't know, 4: partially agree, 5: agree). The findings will be presented descriptively.
Time Frame
one week follow-up
Title
Physicians' acceptability by a global usefulness rating on Likert scales
Description
The physicians' acceptability will be evaluated by a global usefulness rating on Likert scales with five categories after recruitment completion (The ratio of additional effort due to the JGG endoscope(R) and the newly gained information is good, possible answers 1: don't agree, 2: partially don't agree, 3: neutral, 4: partially agree, 5: agree). The findings will be presented descriptively.
Time Frame
6 month
Title
Prevalence of serious adverse events
Description
The number of patients with any serious adverse event within the two weeks follow-up
Time Frame
2 weeks follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults patients aged ≥18 years, with acute rhinosinusitis
Duration: worsening of symptoms after 5 days after onset of symptoms or if symptoms persist for more than 10 days, but no longer than 28 days. In addition, Criteria 1 and 2 must be fulfilled.
Criteria 1 for acute rhinosinusitis:
[Nasal blockage/obstruction/congestion OR Nasal Discharge (anterior/ posterior nasal drip)] AND [Facial pain/ pressure OR Reduction or loss of smell]
Criteria 2 for acute bacterial rhinosinusitis
Indicated by the presence of at least one of the following symptoms:
discoloured discharge (unilateral predominance)
severe local pain (unilateral predominance)
fever, that is >38°C
elevated inflammatory markers (CRP)
'double sickening' whereby the patient's condition deteriorates.
Exclusion Criteria:
Not being able to provide written informed consent in German (due to any mental or intellectual problem or other reasons)
Not being available for follow-up
Previous participation in Sinus-Endo study
Use of antibiotic the last 4 weeks
Known pathology or malformation of the sinuses or nasal cavity (like polyposis)
Known pregnancy
Allergic reactions to local anaesthetics
Anticoagulation therapy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dominik Glinz, Dr. sc.
Phone
+41 61 328 54 02
Email
dominik.glinz@usb.ch
First Name & Middle Initial & Last Name or Official Title & Degree
Heiner C Bucher, Prof.
Phone
+41 61 556 5100
Email
heiner.bucher@usb.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Heiner C Bucher, Prof.
Organizational Affiliation
CEB
Official's Role
Principal Investigator
Facility Information:
Facility Name
Praxis Vogt
City
Liestal
State/Province
BL
ZIP/Postal Code
4410
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jürg Vogt, MD
Phone
+619310080
Facility Name
Hausarztpraxis Muttenz AG
City
Muttenz
State/Province
BL
ZIP/Postal Code
4132
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bernhard Schaller, MD
Phone
+41614612828
Facility Name
mediX toujours Pratteln
City
Pratteln
State/Province
BL
ZIP/Postal Code
4133
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andreas Marti, MD
Phone
+41 61 825 90 90
Facility Name
HNO Klinik, University Hospital Basel
City
Basel
State/Province
BS
ZIP/Postal Code
4031
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katharina Leitmeyer, MD
Phone
+41 61 328 71 08
Facility Name
mediX toujours Basel
City
Basel
State/Province
BS
ZIP/Postal Code
4051
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Caroline Trutmann, MD
Phone
+41 61 500 11 00
Facility Name
Praxis Hammer
City
Basel
State/Province
BS
ZIP/Postal Code
4057
Country
Switzerland
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Claus Diermayr, MD
Phone
+41 61 692 88 11
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
33866681
Citation
Glinz D, Georg Hansen J, Trutmann C, Schaller B, Vogt J, Diermayr C, Marti A, Leitmeyer K, Doerig P, Zeller A, Welge-Luessen Lemcke A, Bucher HC. Single-use device endoscopy for the diagnosis of acute bacterial rhinosinusitis in primary care: A pilot and feasibility study. Clin Otolaryngol. 2021 Sep;46(5):1050-1056. doi: 10.1111/coa.13785. Epub 2021 May 24.
Results Reference
derived
Learn more about this trial
Single Use Device Endoscopy for the Diagnosis of Acute Bacterial Rhinosinusitis in Primary Care
We'll reach out to this number within 24 hrs